Cipher Pharmaceuticals Inc. announced that it will release its financial and operating results for the three and twelve months ended December 31, 2021 after market close on March 17, 2022.
MISSISSAUGA, ON, March 11, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company”) today announced that it will release its financial and operating results for the three and twelve months ended December 31, 2021 after market close on March 17, 2022. The Company will also host a conference call on Friday, March 18, 2022 at 8:30am ET to discuss the results and corporate developments.
| CONFERENCE CALL DETAILS |
| DATE: March 18, 2022 |
| TIME: 8:30 a.m. ET |
| DIAL-IN NUMBER: (647) 794-4605 or (888) 204-4368 |
| CONFERENCE ID: 1673781 |
| REPLAY DIAL-IN: (888) 203-1112 (playback 1673781#) |
| Expires March 25, 2022 |
| WEBCAST: https://produceredition.webcasts.com/starthere.jsp?ei=1533942&tp_key=62d3cb0b34 |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Company Codes: Toronto:CPH
